United States

Optimer Pharmaceuticals LLC (OPTR)

Track

Stock chart
Ticker: OPTR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
LICHTINGER PEDRO
Former CEO
2 sales — total 2,173,991 USD
Sale 8 Apr 2013
Value US$3,224,686.20 | Price 426.31 | Shares 11,312
Sale 8 Apr 2013
Value US$1,553,246.97 | Price 232.67 | Shares 31,502
Buy 8 Nov 2012
Value US$4,910,816.27 | Price 451.54 | Shares 42,336
Sale 11 Jun 2012
Value US$52,953.30 | Price 15.30 | Shares 3,461
Buy 9 Aug 2011
Value US$37,213.00 | Price 7.44 | Shares 5,000
Buy 4 Aug 2011
Value US$224,450.00 | Price 8.98 | Shares 25,000
Sale 12 May 2010
Value US$40,666.75 | Price 11.75 | Shares 3,461
Sale 12 May 2010
Value US$54,226.25 | Price 11.75 | Shares 4,615
Buy 29 Dec 2009
Value US$86,400.00 | Price 10.80 | Shares 8,000
Buy 29 Dec 2009
Value US$86,400.00 | Price 10.80 | Shares 8,000
Buy 28 Dec 2009
Value US$108,500.00 | Price 10.85 | Shares 10,000
Buy 28 Dec 2009
Value US$108,500.00 | Price 10.85 | Shares 10,000
Buy 2 Dec 2009
Value US$5,445.00 | Price 10.89 | Shares 500
Buy 2 Dec 2009
Value US$5,450.00 | Price 10.90 | Shares 500
Buy 2 Dec 2009
Value US$10,960.00 | Price 10.96 | Shares 1,000
Buy 1 Dec 2009
Value US$11,100.00 | Price 11.10 | Shares 1,000
Buy 25 Nov 2009
Value US$80,500.00 | Price 11.50 | Shares 7,000
Buy 25 Nov 2009
Value US$92,240.00 | Price 11.53 | Shares 8,000
Buy 25 Nov 2009
Value US$80,500.00 | Price 11.50 | Shares 7,000
Buy 25 Nov 2009
Value US$92,240.00 | Price 11.53 | Shares 8,000
Buy 18 Jul 2008
Value US$5,333,334.88 | Price 8.48 | Shares 628,931
Buy 18 Jul 2008
Value US$2,666,663.20 | Price 8.48 | Shares 314,465
Sale 2 Jul 2008
Value US$59,200.00 | Price 7.40 | Shares 8,000
Sale 2 Jul 2008
Value US$1,420,800.00 | Price 7.40 | Shares 192,000
Buy 13 Jun 2008
Value US$35,000.00 | Price 7.00 | Shares 5,000
Buy 13 Jun 2008
Value US$35,000.00 | Price 7.00 | Shares 5,000
Planned buy 15 May 2008
Value US$15,087.50 | Price 6.04 | Shares 2,500
Planned buy 15 May 2008
Value US$12,323.47 | Price 6.04 | Shares 2,042
Sale 19 Dec 2007
Value US$94,683.00 | Price 7.75 | Shares 12,220
Sale 18 Dec 2007
Value US$11,291.83 | Price 7.71 | Shares 1,464
Sale 18 Dec 2007
Value US$176,905.37 | Price 7.71 | Shares 22,936
Sale 17 Dec 2007
Value US$5,828.99 | Price 7.71 | Shares 756
Sale 17 Dec 2007
Value US$91,320.79 | Price 7.71 | Shares 11,844
Sale 13 Dec 2007
Value US$6,043.60 | Price 7.75 | Shares 780
Sale 13 Dec 2007
Value US$2,568.83 | Price 7.38 | Shares 348
Sale 13 Dec 2007
Value US$40,245.03 | Price 7.38 | Shares 5,452
Buy 15 Nov 2007
Value US$5,950.00 | Price 5.95 | Shares 1,000
Buy 15 Nov 2007
Value US$5,950.00 | Price 5.95 | Shares 1,000
Planned buy 15 Nov 2007
Value US$5,950.00 | Price 5.95 | Shares 1,000
Planned buy 15 Nov 2007
Value US$5,950.00 | Price 5.95 | Shares 1,000
Planned buy 15 Nov 2007
Value US$5,950.00 | Price 5.95 | Shares 1,000
Planned buy 15 Nov 2007
Value US$5,950.00 | Price 5.95 | Shares 1,000
Planned buy 15 Nov 2007
Value US$5,950.00 | Price 5.95 | Shares 1,000
Buy 10 Aug 2007
Value US$2,472.00 | Price 8.24 | Shares 300
Buy 10 Aug 2007
Value US$1,654.00 | Price 8.27 | Shares 200
Buy 10 Aug 2007
Value US$828.00 | Price 8.28 | Shares 100
Buy 10 Aug 2007
Value US$1,658.00 | Price 8.29 | Shares 200
Buy 10 Aug 2007
Value US$9,960.00 | Price 8.30 | Shares 1,200
Buy 9 Aug 2007
Value US$4,150.00 | Price 8.30 | Shares 500
Buy 9 Aug 2007
Value US$246,000.00 | Price 8.20 | Shares 30,000
Buy 9 Aug 2007
Value US$246,000.00 | Price 8.20 | Shares 30,000
Buy 6 Aug 2007
Value US$90,500.00 | Price 9.05 | Shares 10,000
Buy 6 Aug 2007
Value US$90,500.00 | Price 9.05 | Shares 10,000
Buy 16 Jul 2007
Value US$49,000.00 | Price 9.80 | Shares 5,000
Buy 16 Jul 2007
Value US$49,600.00 | Price 9.92 | Shares 5,000
Buy 16 Jul 2007
Value US$49,000.00 | Price 9.80 | Shares 5,000
Buy 16 Jul 2007
Value US$49,600.00 | Price 9.92 | Shares 5,000
Sale 21 Feb 2007
Value US$7,350,000.00 | Price 7.00 | Shares 1,050,000
Buy 14 Feb 2007
Value US$804,755.00 | Price 7.00 | Shares 114,965
Buy 14 Feb 2007
Value US$4,200.00 | Price 7.00 | Shares 600
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2013-04-10 2013-04-08 S Sale LICHTINGER PEDRO

Former CEO
11,312 +43.2%
426.31
US$3,224,686 		11,312 +43.2% 426.31 US$3,224,686
2013-04-10 2013-04-08 S Sale LICHTINGER PEDRO

Former CEO
31,502 -45.5%
232.67
US$1,553,247 		31,502 -45.5% 232.67 US$1,553,247
2012-11-19 2012-11-08 B Purchase LICHTINGER PEDRO

CEO and President

Officer
42,336 -31.0%
451.54
US$4,910,816 		42,336 -31.0% 451.54 US$4,910,816
2012-06-20 2012-06-11 S Sale CHANG JOSEPH Y Non-Executive Director
3,461 -3.3%
15.30
US$52,953 		3,461 -3.3% 15.30 US$52,953
2011-08-09 2011-08-09 B Purchase ALTIG ANTHONY E Non-Executive Director
5,000 +inf%
7.44
US$37,213 		5,000 +inf% 7.44 US$37,213
2011-08-04 2011-08-04 B Purchase LICHTINGER PEDRO

CEO and President

Executive Director
25,000 +38.0%
8.98
US$224,450 		25,000 +38.0% 8.98 US$224,450
2010-05-13 2010-05-12 S Sale CHANG JOSEPH Y Non-Executive Director
3,461 -3.5%
11.75
US$40,667 		3,461 -3.5% 11.75 US$40,667
2010-05-13 2010-05-12 S Sale CHANG JOSEPH Y Non-Executive Director
4,615 -4.6%
11.75
US$54,226 		4,615 -4.6% 11.75 US$54,226
2009-12-29 2009-12-29 B Purchase Chang Michael N

CEO and President

Executive Director
8,000 +3.8%
10.80
US$86,400 		8,000 +3.8% 10.80 US$86,400
2009-12-29 2009-12-29 B Purchase Che Tessie M

COO and SVP

Officer
8,000 +3.8%
10.80
US$86,400 		8,000 +3.8% 10.80 US$86,400
2009-12-29 2009-12-28 B Purchase Chang Michael N

CEO and President

Executive Director
10,000 +4.9%
10.85
US$108,500 		10,000 +4.9% 10.85 US$108,500
2009-12-29 2009-12-28 B Purchase Che Tessie M

COO and SVP

Officer
10,000 +4.9%
10.85
US$108,500 		10,000 +4.9% 10.85 US$108,500
2009-12-02 2009-12-02 B Purchase Shue Youe Kong

VP, Clinical Development

Officer
500 +0.6%
10.89
US$5,445 		500 +0.6% 10.89 US$5,445
2009-12-02 2009-12-02 B Purchase Shue Youe Kong

VP, Clinical Development

Officer
500 +0.6%
10.90
US$5,450 		500 +0.6% 10.90 US$5,450
2009-12-02 2009-12-02 B Purchase Shue Youe Kong

VP, Clinical Development

Officer
1,000 +1.2%
10.96
US$10,960 		1,000 +1.2% 10.96 US$10,960
2009-12-02 2009-12-01 B Purchase Shue Youe Kong

VP, Clinical Development

Officer
1,000 +1.3%
11.10
US$11,100 		1,000 +1.3% 11.10 US$11,100
2009-11-25 2009-11-25 B Purchase Che Tessie M

COO and SVP

Officer
7,000 +3.6%
11.50
US$80,500 		7,000 +3.6% 11.50 US$80,500
2009-11-25 2009-11-25 B Purchase Chang Michael N

CEO and President

Executive Director
7,000 +3.6%
11.50
US$80,500 		7,000 +3.6% 11.50 US$80,500
2009-11-25 2009-11-25 B Purchase Che Tessie M

COO and SVP

Officer
8,000 +4.3%
11.53
US$92,240 		8,000 +4.3% 11.53 US$92,240
2009-11-25 2009-11-25 B Purchase Chang Michael N

CEO and President

Executive Director
8,000 +4.3%
11.53
US$92,240 		8,000 +4.3% 11.53 US$92,240
2008-07-22 2008-07-18 B Purchase SCHREIBER ALAIN Non-Executive Director
628,931 +inf%
8.48
US$5,333,335 		628,931 +inf% 8.48 US$5,333,335
2008-07-22 2008-07-18 B Purchase SCHREIBER ALAIN Non-Executive Director
314,465 +inf%
8.48
US$2,666,663 		314,465 +inf% 8.48 US$2,666,663
2008-07-25 2008-07-02 S Sale EDELMAN JOSEPH Large shareholder
8,000 -6.6%
7.40
US$59,200 		8,000 -6.6% 7.40 US$59,200
2008-07-25 2008-07-02 S Sale EDELMAN JOSEPH Large shareholder
192,000 -7.0%
7.40
US$1,420,800 		192,000 -7.0% 7.40 US$1,420,800
2008-06-17 2008-06-13 B Purchase Chang Michael N

CEO and President

Executive Director
5,000 +3.0%
7.00
US$35,000 		5,000 +3.0% 7.00 US$35,000
2008-06-17 2008-06-13 B Purchase Che Tessie M

COO and SVP

Officer
5,000 +3.0%
7.00
US$35,000 		5,000 +3.0% 7.00 US$35,000
2008-05-16 2008-05-15 PP Planned purchase Che Tessie M

COO & SVP

Officer
2,500 +1.5%
6.04
US$15,088 		2,500 +1.5% 6.04 US$15,088
2008-05-16 2008-05-15 PP Planned purchase Chang Michael N

CEO & President

Executive Director
2,042 +0.8%
6.04
US$12,323 		2,042 +0.8% 6.04 US$12,323
2007-12-27 2007-12-19 S Sale EDELMAN JOSEPH Large shareholder
12,220 -0.4%
7.75
US$94,683 		12,220 -0.4% 7.75 US$94,683
2007-12-27 2007-12-18 S Sale EDELMAN JOSEPH Large shareholder
1,464 -1.2%
7.71
US$11,292 		1,464 -1.2% 7.71 US$11,292
2007-12-27 2007-12-18 S Sale EDELMAN JOSEPH Large shareholder
22,936 -0.8%
7.71
US$176,905 		22,936 -0.8% 7.71 US$176,905
2007-12-27 2007-12-17 S Sale EDELMAN JOSEPH Large shareholder
756 -0.6%
7.71
US$5,829 		756 -0.6% 7.71 US$5,829
2007-12-27 2007-12-17 S Sale EDELMAN JOSEPH Large shareholder
11,844 -0.4%
7.71
US$91,321 		11,844 -0.4% 7.71 US$91,321
2007-12-27 2007-12-13 S Sale EDELMAN JOSEPH Large shareholder
780 -0.6%
7.75
US$6,044 		780 -0.6% 7.75 US$6,044
2007-12-27 2007-12-13 S Sale EDELMAN JOSEPH Large shareholder
348 -0.3%
7.38
US$2,569 		348 -0.3% 7.38 US$2,569
2007-12-27 2007-12-13 S Sale EDELMAN JOSEPH Large shareholder
5,452 -0.2%
7.38
US$40,245 		5,452 -0.2% 7.38 US$40,245
2007-11-19 2007-11-15 B Purchase Chang Michael N

CEO

Executive Director
1,000 +0.4%
5.95
US$5,950 		1,000 +0.4% 5.95 US$5,950
2007-11-19 2007-11-15 PP Planned purchase Che Tessie M

COO

Officer
1,000 +0.6%
5.95
US$5,950 		1,000 +0.6% 5.95 US$5,950
2007-11-19 2007-11-15 B Purchase Chang Michael N

CEO

Executive Director
1,000 +0.6%
5.95
US$5,950 		1,000 +0.6% 5.95 US$5,950
2007-11-19 2007-11-15 PP Planned purchase Poulos Kevin P

Chief Commercial Officer

Officer
1,000 +166.7%
5.95
US$5,950 		1,000 +166.7% 5.95 US$5,950
2007-11-19 2007-11-15 PP Planned purchase Che Tessie M

COO

Officer
1,000 +0.4%
5.95
US$5,950 		1,000 +0.4% 5.95 US$5,950
2007-11-19 2007-11-15 PP Planned purchase Prunty John D

CFO

Officer
1,000 +inf%
5.95
US$5,950 		1,000 +inf% 5.95 US$5,950
2007-11-19 2007-11-15 PP Planned purchase Shue Youe Kong

VP Clinical Development

Officer
1,000 +1.3%
5.95
US$5,950 		1,000 +1.3% 5.95 US$5,950
2007-08-13 2007-08-10 B Purchase Shue Youe Kong

VP Clinical Development

Officer
300 +0.4%
8.24
US$2,472 		300 +0.4% 8.24 US$2,472
2007-08-13 2007-08-10 B Purchase Shue Youe Kong

VP Clinical Development

Officer
200 +0.3%
8.27
US$1,654 		200 +0.3% 8.27 US$1,654
2007-08-13 2007-08-10 B Purchase Shue Youe Kong

VP Clinical Development

Officer
100 +0.1%
8.28
US$828 		100 +0.1% 8.28 US$828
2007-08-13 2007-08-10 B Purchase Shue Youe Kong

VP Clinical Development

Officer
200 +0.3%
8.29
US$1,658 		200 +0.3% 8.29 US$1,658
2007-08-13 2007-08-10 B Purchase Shue Youe Kong

VP Clinical Development

Officer
1,200 +1.7%
8.30
US$9,960 		1,200 +1.7% 8.30 US$9,960
2007-08-13 2007-08-09 B Purchase Shue Youe Kong

VP Clinical Development

Officer
500 +0.7%
8.30
US$4,150 		500 +0.7% 8.30 US$4,150
2007-08-10 2007-08-09 B Purchase Chang Michael N

President & CEO

Executive Director
30,000 +21.5%
8.20
US$246,000 		30,000 +21.5% 8.20 US$246,000
2007-08-10 2007-08-09 B Purchase Che Tessie M

Senior VP & COO

Officer
30,000 +21.5%
8.20
US$246,000 		30,000 +21.5% 8.20 US$246,000
2007-08-08 2007-08-06 B Purchase Che Tessie M

Senior VP & COO

Officer
10,000 +7.7%
9.05
US$90,500 		10,000 +7.7% 9.05 US$90,500
2007-08-08 2007-08-06 B Purchase Chang Michael N

President and CEO

Executive Director
10,000 +7.7%
9.05
US$90,500 		10,000 +7.7% 9.05 US$90,500
2007-08-08 2007-07-16 B Purchase Che Tessie M

Senior VP & COO

Officer
5,000 +4.0%
9.80
US$49,000 		5,000 +4.0% 9.80 US$49,000
2007-08-08 2007-07-16 B Purchase Che Tessie M

Senior VP & COO

Officer
5,000 +4.2%
9.92
US$49,600 		5,000 +4.2% 9.92 US$49,600
2007-07-18 2007-07-16 B Purchase Chang Michael N

President, CEO

Executive Director
5,000 +4.0%
9.80
US$49,000 		5,000 +4.0% 9.80 US$49,000
2007-07-18 2007-07-16 B Purchase Chang Michael N

President, CEO

Executive Director
5,000 +4.2%
9.92
US$49,600 		5,000 +4.2% 9.92 US$49,600
2007-02-23 2007-02-21 S Sale Par Pharmacuetical, Inc. Large shareholder
1,050,000 -45.5%
7.00
US$7,350,000 		1,050,000 -45.5% 7.00 US$7,350,000
2007-02-14 2007-02-14 B Purchase Chang Michael N

President, CEO

Executive Director
114,965 +2491.1%
7.00
US$804,755 		114,965 +2491.1% 7.00 US$804,755
2007-02-14 2007-02-14 B Purchase Poulos Kevin P

VP, Marketing and Sales

Officer
600 +inf%
7.00
US$4,200 		600 +inf% 7.00 US$4,200
Explore more

More insider trading research around Optimer Pharmaceuticals LLC

More insider trades in United States
Insider trading in North America